A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer

SSRN Electronic Journal 2026 Preprint Open access

Read full text
Authors: Alessandro Davide Santin, Dana M. Roque, Eric R. Siegel
DOI: 10.2139/ssrn.5982295
Cited by: 0

Fields of Study & Subjects

Endometrial and Cervical Cancer Treatments HER2/EGFR in Cancer Research Uterine Myomas and Treatments

Publication details

Journal / source
SSRN Electronic Journal
Publication date
1 January 2026
Document type
Preprint